Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres.
about
Current status of transarterial radioembolizationMetastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.Outcomes and Predictors of Toxicity after Selective Internal Radiation Therapy Using Yttrium-90 Resin Microspheres for Unresectable Hepatocellular Carcinoma.Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients treated with selective internal radiation therapy.Administered activity and outcomes of glass versus resin (90)Y microsphere radioembolization in patients with colorectal liver metastases.Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancerMetabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with 90Y Radioembolization.The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres.Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases.A single institute retrospective trial of concurrent chemotherapy with SIR-Spheres® versus SIR-Spheres® alone in chemotherapy-resistant colorectal cancer liver metastases.Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.
P2860
Q26744307-08C49D1E-00B9-4124-A9E7-E591630BE90AQ36392298-AB2DCCEE-25F5-4066-8A02-2EC298E338ACQ36396455-FEF794BE-8CED-4BC4-95C4-6C1CD6AE631EQ36666680-15A62066-5360-4E05-A005-D5C35E317A04Q37131705-61D3A455-1F46-40A8-8FC4-C7F7F936B38AQ37601096-9F165C26-5B04-4E1A-BA22-ED8482F8B163Q37677524-615E39E9-D7BF-40EE-AF1E-997CBD7FAB00Q38830196-398A14DE-7896-44B3-92EC-045395790419Q38888162-FDE3DF1F-38C9-477B-9699-87E3E87C0196Q38903862-BF3F0FC6-A977-43C2-8443-C998AECD745CQ39456177-43933EEB-0742-4A72-AACA-B133A6BB02DDQ41598539-3DE6F021-72AE-4E75-AEE4-FD74AE77DD51Q41598591-C346A93C-3557-45ED-82A6-EB4684EE47FCQ47134709-496CD0DF-0AB0-4FA9-AE38-82C18C5D11A7
P2860
Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Multicenter evaluation of the ...... for (90)Y resin microspheres.
@ast
Multicenter evaluation of the ...... for (90)Y resin microspheres.
@en
type
label
Multicenter evaluation of the ...... for (90)Y resin microspheres.
@ast
Multicenter evaluation of the ...... for (90)Y resin microspheres.
@en
prefLabel
Multicenter evaluation of the ...... for (90)Y resin microspheres.
@ast
Multicenter evaluation of the ...... for (90)Y resin microspheres.
@en
P2093
P2860
P1476
Multicenter evaluation of the ...... for (90)Y resin microspheres.
@en
P2093
Alain Drooz
Andrew S Kennedy
Charles W Nutting
David Ball
Douglas M Coldwell
Eduardo Ehrenwald
Eric A Wang
Fred M Moeslein
Michael A Savin
Michael Cohn
P2860
P304
P356
10.3978/J.ISSN.2078-6891.2014.109
P577
2015-04-01T00:00:00Z